Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis

What is it about?

Atrial fibrillation (AF) is common in individuals receiving dialysis. The role of oral anticoagulation (OAC) in this population is uncertain given its exclusion from previous seminal clinical trials. Our objective was to determine the feasibility of performing a large definitive trial to establish the optimal anticoagulation strategy in individuals with AF receiving dialysis.

Featured Image